Management Strategies for Vancomycin-Resistant Enterococci (VRE) Colonization
Strict infection control measures including patient isolation, proper hand hygiene, and environmental decontamination are the cornerstone of VRE colonization management to prevent transmission and reduce morbidity and mortality. 1
Surveillance and Detection
Early identification of VRE colonization is crucial for effective management:
Perform periodic surveillance cultures (stool or rectal swabs) in high-risk patients:
- ICU patients
- Oncology patients
- Transplant recipients
- Patients hospitalized for >5-7 days
- Patients transferred from facilities with known VRE cases 1
Use selective media containing vancomycin to improve detection efficiency 1
Screen roommates of newly identified VRE-positive patients to determine colonization status 1
Isolation and Contact Precautions
Once VRE colonization is identified:
Place colonized patients in private rooms or cohort with other VRE-positive patients 1
Implement strict contact precautions:
- Wear gloves when entering the room (clean, non-sterile gloves are adequate)
- Wear gowns when substantial patient contact is anticipated, especially for patients who are incontinent or have wounds, ostomies, or diarrhea
- Remove gloves and gown before leaving the room
- Perform hand hygiene with antiseptic soap or waterless antiseptic agent immediately after glove removal 1
Dedicate non-critical medical equipment (stethoscopes, blood pressure cuffs, thermometers) to VRE-positive patients or ensure proper cleaning between patients 1
Environmental Control
Environmental contamination plays a significant role in VRE transmission:
Verify adequate procedures for routine cleaning and disinfection of environmental surfaces (bed rails, doorknobs, faucet handles, bedside commodes) 1
Consider environmental cultures before and after cleaning rooms of VRE-positive patients to verify efficacy of cleaning protocols in facilities with ongoing transmission 1
Staff Management
Healthcare workers are important vectors for VRE transmission:
When feasible, cohort staff to minimize movement between VRE-positive and VRE-negative patients 1
Provide ongoing education about VRE transmission and control measures 1
Establish monitoring systems for compliance with isolation precautions and hand hygiene 1
Duration of Precautions
VRE colonization can persist indefinitely, requiring careful consideration for discontinuing precautions:
Adopt stringent criteria for removing patients from isolation, such as VRE-negative results on at least three consecutive occasions (≥1 week apart) from multiple body sites (stool/rectal swab, perineal area, axilla/umbilicus, wounds, catheter sites) 1
Establish a system to flag medical records of previously colonized patients to ensure prompt isolation upon readmission 1
Special Considerations for High-Risk Populations
Certain populations require additional attention:
Neonatal ICUs: VRE colonization rates can be significantly reduced (from 67% to 7%) with strict infection control measures 2
Premature infants and low birth weight neonates are at higher risk for VRE colonization 3
Hematology/oncology patients, ICU patients, and solid organ transplant recipients are at increased risk of developing infections from colonization 4
Novel Approaches
Emerging strategies for managing VRE colonization include:
Fecal microbiota transplantation (FMT) has shown promising results in reestablishing gut microbiota diversity and reducing VRE dominance in the gastrointestinal tract 5
Bacteriophage therapy may be a future strategy for eradicating VRE from the gut 5
Antibiotic Stewardship
Antibiotic exposure significantly contributes to VRE colonization and transmission:
Implement antibiotic stewardship programs to reduce unnecessary antibiotic use 5, 6
Duration of vancomycin use has been identified as an independent risk factor for VRE development in neonates 3
Treatment Considerations
While colonization itself doesn't require treatment, infections require appropriate antibiotics:
Linezolid has demonstrated efficacy in treating VRE infections with cure rates of 67% for various infection sites and 59% for bacteremia 7
Daptomycin at higher doses (10-12 mg/kg) alone or in combination with β-lactams may be needed for deep-seated infections 5
Institutional Approach
VRE management requires a coordinated institutional effort:
Develop a collaborative, institution-wide, multidisciplinary approach 1
Involve quality assurance/improvement departments to identify and address systemic issues 1
Establish monitoring systems for both process measures (compliance with precautions) and outcome measures (VRE colonization rates) 1
Coordinate with local and state health departments when developing discharge plans for VRE-colonized patients 1